About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySeattle/Pacific Northwest
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
1,697
By Phase
EARLY_PHASE1: 1PHASE2/PHASE3: 1PHASE1: 3PHASE2: 1
By Status
COMPLETED: 4RECRUITING: 3
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06556940Lead Sponsor
G.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies
EARLY_PHASE1Recruiting
12 participants
Started: Dec 4, 2024 · Completed: Dec 2, 2025
NCT05330182Lead Sponsor
LMN-201 for Prevention of C. Difficile Infection Recurrence
PHASE2/PHASE3Recruiting
375 participants
Started: Aug 29, 2024 · Completed: Apr 1, 2026
NCT06363890Lead Sponsor
Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia
N/ARecruiting
1,200 participants
Started: Jun 20, 2024 · Completed: Jul 1, 2026
NCT06030414Lead Sponsor
A Study to Determine the Tolerability of Intranasal LMN-301
PHASE1Completed
35 participants
Started: Oct 6, 2023 · Completed: Apr 3, 2024
NCT04182490Lead Sponsor
LMN-101 in a Campylobacter Human Challenge Model
PHASE2Completed
42 participants
Started: Feb 21, 2022 · Completed: Oct 4, 2022
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...